AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H101. A total of 152 filers reported holding AMYLYX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $684,263 | +1585.6% | 37,371 | +1885.7% | 0.00% | – |
Q2 2023 | $40,595 | -61.6% | 1,882 | -47.8% | 0.00% | – |
Q1 2023 | $105,683 | -88.8% | 3,602 | -85.9% | 0.00% | -100.0% |
Q4 2022 | $943,629 | -62.3% | 25,538 | -71.3% | 0.00% | -60.0% |
Q3 2022 | $2,505,000 | -16.3% | 88,985 | -42.7% | 0.01% | 0.0% |
Q2 2022 | $2,993,000 | +18606.2% | 155,388 | +12401.0% | 0.01% | – |
Q1 2022 | $16,000 | – | 1,243 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alpha Wave Global, LP | 930,337 | $27,296,088 | 10.08% |
Perceptive Advisors | 6,034,644 | $177,056,455 | 5.23% |
GREAT POINT PARTNERS LLC | 783,795 | $22,996,545 | 4.52% |
Ghost Tree Capital, LLC | 475,000 | $13,937,000 | 4.12% |
Altium Capital Management LP | 185,000 | $5,427,900 | 3.01% |
Boxer Capital, LLC | 2,084,000 | $61,145 | 3.00% |
EMERALD MUTUAL FUND ADVISERS TRUST | 789,591 | $23,166,600 | 1.37% |
EMERALD ADVISERS, LLC | 972,835 | $28,542,979 | 1.37% |
SECTORAL ASSET MANAGEMENT INC | 242,400 | $7,112,016 | 1.37% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,984,333 | $58,220,330 | 1.30% |